The underlying pathology is termed frontotemporal lobar degeneration (FTLD) and consists of distinct underlying pathologies including aggregation of transactive response DNA-binding protein 43 (TDP-43), tau and fused-in-sarcoma (FUS) [7]. The gene discussed is FUS; the disease is frontotemporal dementia.